Ipamorelin is a synthetic pentapeptide ghrelin-receptor agonist (Aib-His-D-2-Nal-D-Phe-Lys-NH2), CAS 170851-70-4, molecular weight 711.9 Da. It selectively activates the ghrelin receptor (GHSR-1a) with high specificity. Research examines its signaling effects without significant impact on cortisol or prolactin. Compuesto para investigación — not for human use.
Especificaciones del compuesto
Ipamorelin is a synthetic pentapeptide ghrelin-receptor agonist (Aib-His-D-2-Nal-D-Phe-Lys-NH₂), CAS 170851-70-4. Molecular weight 711.85 Da. It is a selective agonist of the ghrelin receptor (GHS-R1a) and is characterized by high selectivity in receptor-signaling assays without significant effects on other pituitary hormones. Compuesto para investigación — not for human use.
Detalles del producto
- Tamaños: 5mg, 10mg
- Compuesto: Ipamorelin
- Secuencia: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Pureza: >99%
- Forma: Polvo liofilizado
- Pruebas: Ver COA (Verificado por Janoshik) →
mg, 10mg
📚 Ver investigación publicada sobre Ipamorelin →
Citas revisadas por pares de PubMed, solo con fines educativos
Ipamorelin documentation path
This Ipamorelin listing is organized for sequence identity, receptor-family context, and batch documentation before researchers compare the catalog record with published GH-axis literature.
- Identidad: synthetic pentapeptide ghrelin-receptor agonist; sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2; CAS 170851-70-4.
- Documentation: review COA records y Calidad y pruebas for batch-verification standards.
- Literature context: see Ipamorelin research, Sermorelin research, y CJC-1295 + Ipamorelin research.
Research use only. This page does not provide dosing, administration, reconstitution, treatment, hormone-use, or human-use guidance.